Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways.
about
Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015)How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosisLiver X Receptor Agonist TO901317 Attenuates Paraquat-Induced Acute Lung Injury through Inhibition of NF-κB and JNK/p38 MAPK Signal Pathways.Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21.A brief review: adipose-derived stem cells and their therapeutic potential in cardiovascular diseases.Emerging role of liver X receptors in cardiac pathophysiology and heart failure.The Role of bFGF in the Excessive Activation of Astrocytes Is Related to the Inhibition of TLR4/NFκB Signals.Hyperglycemia Suppresses Calcium Phosphate-Induced Aneurysm Formation Through Inhibition of Macrophage ActivationMesenchymal stem cells in alleviating sepsis-induced mice cardiac dysfunction via inhibition of mTORC1-p70S6K signal pathway.Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.Melatonin facilitates adipose-derived mesenchymal stem cells to repair the murine infarcted heart via the SIRT1 signaling pathway.Increased mortality and aggravation of heart failure in liver X receptor-α knockout mice after myocardial infarction.Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation
P2860
Q26748751-7C32EF47-DC66-40BB-B4F5-DAD69887634BQ26774939-96CA0945-A06D-45A9-BA14-D2458206A266Q28468333-0C04DF22-FE00-4738-9FBB-A2B8D93B21A8Q30357063-7EB17B51-CA3D-4455-91A1-7F7A58B1C393Q33722181-E5422ED3-9128-474E-9E26-26F9ACA9B353Q33768499-6C020E6F-0CB3-4C66-992F-63F947F2170AQ36322805-843EE3FA-A119-4286-9AB9-0DB415247894Q36512436-15373D77-17F5-4730-92A5-82F674908324Q37090851-DAB2E1B2-5A1A-46D1-BFB7-F11C11A9F714Q37668484-35690CA6-E013-4CA2-9550-C8D1D5A10B74Q37716622-092FACC0-3047-4FD9-AC10-1C9B86D36FE6Q40274980-13BF3BC2-4433-4A2B-897A-5B2B0782AD8DQ40986115-8BDC872C-D5F0-4874-B345-F6C686C23EFDQ42371477-6E135AED-1D8A-4DD9-A228-70F954E30AAF
P2860
Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@ast
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@en
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@nl
type
label
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@ast
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@en
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@nl
prefLabel
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@ast
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@en
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@nl
P2093
P2860
P356
P1476
Activation of liver X receptor ...... ap-1/Nrf-2 signaling pathways.
@en
P2093
Chunhong Li
Jiangwei Chen
Kang Cheng
Kazim Narsinh
Rongqing Zhang
P2860
P304
P356
10.1089/ARS.2013.5683
P577
2014-07-31T00:00:00Z